{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T23:23:55Z","timestamp":1768951435145,"version":"3.49.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,3]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Autoimmunity targeting glutamic acid decarboxylase 65 (GAD65) is associated with type 1 diabetes mellitus as well as various neurological diseases. In the central nervous system, GAD65 autoimmunity usually presents with limbic encephalitis, whereas extralimbic encephalitis (ELE) has only been reported in a few cases. Moreover, anti-GAD65 ELE in the paraneoplastic context has not yet been reported.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 60-year-old man presented with intermittent cough and sputum for 10 years, with no other diseases. The patient presented with recurrent seizures that were resistant to antiepileptic drugs (AEDs). Chest computed tomography and pathological results confirmed the diagnosis of small cell lung cancer. Paraneoplastic testing found a high level of GAD65 antibodies in his serum, and cerebrospinal fluid analysis revealed lymphocytic pleocytosis, indicating autoimmune encephalitis. Brain magnetic resonance imaging showed multifocal T2 fluid-attenuated inversion recovery hyperintensities in the extralimbic areas including the subcortex and deep white matter of the bilateral frontal lobe, parietal lobe, and insula lobes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Finally, a diagnosis of anti-GAD65 autoimmune ELE with a paraneoplastic etiology from the small cell lung cancer was suspected.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient refused any tumor-suppressive treatment or immunotherapy for potential side effects and only received AEDs levetiracetam, sodium valproate, and diazepam.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The epilepsy of the patient was resistant to AEDs, and the patient died a week after discharge due to disease progression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Anti-GAD65 autoimmune encephalitis can be extralimbic, can present with isolated epilepsy, and extralimbic anti-GAD65 encephalitis can occur with an underlying malignancy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000034780","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T09:14:43Z","timestamp":1701162883000},"page":"e34780","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Paraneoplastic anti-GAD65 extralimbic encephalitis presented with epilepsy: A case report"],"prefix":"10.1097","volume":"102","author":[{"given":"Si-Qi","family":"Xia","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China"},{"name":"Clinical Research Center for Neurological Diseases of Zhejiang Province, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao-Nan","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Jiujiang University, Jiujiang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-Feng","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China"},{"name":"Clinical Research Center for Neurological Diseases of Zhejiang Province, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wu","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Fourth Affiliated Hospital, School of Medicine, Zhejiang University, Yiwu, Zhejiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China"},{"name":"Clinical Research Center for Neurological Diseases of Zhejiang Province, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fneur.2018.00579","article-title":"Clinical management of epilepsy with glutamic acid decarboxylase antibody positivity: the interplay between immunotherapy and anti-epileptic drugs.","volume":"9","author":"M\u00e4kel\u00e4","year":"2018","journal-title":"Front Neurol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/jamaneurol.2015.0749","article-title":"Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies.","volume":"72","author":"Ari\u00f1o","year":"2015","journal-title":"JAMA Neurol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.yebeh.2011.03.038","article-title":"Extralimbic autoimmune encephalitis associated with glutamic acid decarboxylase antibodies: an underdiagnosed entity?","volume":"21","author":"Najjar","year":"2011","journal-title":"Epilepsy Behav"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1684\/epd.2014.0666","article-title":"PET-positive extralimbic presentation of anti-glutamic acid decarboxylase antibody-associated encephalitis.","volume":"16","author":"Kojima","year":"2014","journal-title":"Epileptic Disord"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41582-020-0359-x","article-title":"GAD antibodies in neurological disorders - insights and challenges.","volume":"16","author":"Graus","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.yebeh.2018.01.021","article-title":"Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy.","volume":"80","author":"Daif","year":"2018","journal-title":"Epilepsy Behav"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamaneurol.2016.5429","article-title":"Neurological autoantibody prevalence in epilepsy of unknown etiology.","volume":"74","author":"Dubey","year":"2017","journal-title":"JAMA Neurol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1017\/cjn.2016.13","article-title":"Limbic encephalitis associated with GAD65 antibodies: brief review of the relevant literature.","volume":"43","author":"Gagnon","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jamaneurol.2021.3113","article-title":"Discerning the role of autoimmunity and autoantibodies in epilepsy: a review.","volume":"78","author":"Steriade","year":"2021","journal-title":"JAMA Neurol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","article-title":"Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management.","volume":"92","author":"Abboud","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/jnnp-2020-325275","article-title":"Clinical spectrum of high-titre GAD65 antibodies.","volume":"92","author":"Budhram","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"e0191794","DOI":"10.1371\/journal.pone.0191794","article-title":"Enhanced susceptibility to stress and seizures in GAD65 deficient mice.","volume":"13","author":"Qi","year":"2018","journal-title":"PLoS One"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1111\/j.1528-1167.2010.02644.x","article-title":"Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels.","volume":"51","author":"Stagg","year":"2010","journal-title":"Epilepsia"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fncel.2016.00130","article-title":"Anti-GAD65 containing cerebrospinal fluid does not alter GABAergic transmission.","volume":"10","author":"Hackert","year":"2016","journal-title":"Front Cell Neurosci"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fneur.2015.00189","article-title":"Serum from a patient with GAD65 antibody-associated limbic encephalitis did not alter GABAergic neurotransmission in cultured hippocampal networks.","volume":"6","author":"Stemmler","year":"2015","journal-title":"Front Neurol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"577063","DOI":"10.1016\/j.jneuroim.2019.577063","article-title":"Predictive value of high titer of GAD65 antibodies in a case of limbic encephalitis.","volume":"337","author":"Di Giacomo","year":"2019","journal-title":"J Neuroimmunol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.13297","article-title":"Distinct white matter integrity in glutamic acid decarboxylase and voltage-gated potassium channel-complex antibody-associated limbic encephalitis.","volume":"57","author":"Wagner","year":"2016","journal-title":"Epilepsia"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/mus.25565","article-title":"GAD65 neurological autoimmunity.","volume":"56","author":"McKeon","year":"2017","journal-title":"Muscle Nerve"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yebeh.2016.04.046","article-title":"Paraneoplastic epilepsy.","volume":"61","author":"Serafini","year":"2016","journal-title":"Epilepsy Behav"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5692\/clinicalneurol.50.92","article-title":"[A case of immune-mediated encephalopathy showing refractory epilepsy and extensive brain MRI lesions associated with anti-glutamic acid decarboxylase antibody].","volume":"50","author":"Kobayakawa","year":"2010","journal-title":"Rinsho Shinkeigaku"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jneuroim.2018.06.013","article-title":"Fulminant anti-GAD antibody encephalitis presenting with status epilepticus requiring aggressive immunosuppression.","volume":"323","author":"Triplett","year":"2018","journal-title":"J Neuroimmunol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/1759-7714.13009","article-title":"Paraneoplastic autoimmunity and small-cell lung cancer: neurological and serological accompaniments.","volume":"10","author":"Zekeridou","year":"2019","journal-title":"Thorac Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034780","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:18:35Z","timestamp":1746325115000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":23,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034780","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,3]]}}}